Skip to main content
. 2018 Sep 14;293(43):16546–16558. doi: 10.1074/jbc.RA118.004929

Table 1.

The comparison of CBD to phenytoin and carbamazepine

Parameter Cannabidiol Phenytoin Carbamazepine
Brain–lipid binding–TRANSIL (%) 99.6 98.5 83.7
Plasma–protein binding (%) ∼95–99a 95a ∼70a
IC50 on Nav channels (μm) 1–4 ∼10a ∼25a
ED50 MES (mg/kg) ∼120a 8.2–17.5a 7.5a
Efficacious plasma level (μm) 6.4–8.3a 4–10a 5–12a
Brain concentration (μm) 21.9a 86a 9.7a
Brain/IC50 (ratio) 5.5–21.9 8.6 0.4

a These parameters were taken from literature (5, 6, 39, 4148, 5759).